Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer-Reference-Cited by-同舟云学术

Impact of the 2018 ASCO/CAP HER2 guidelines update for HER2 testing by FISH in breast cancer

Published:2019-02 Issue:2 Volume:215 Page:251-255
ISSN:0344-0338
Container-title:Pathology - Research and Practice
language:en
Short-container-title:Pathology - Research and Practice

Author:

Xu Bin,Shen Jianguo,Guo Wenhao,Zhao Wenhe,Zhuang Yiyu,Wang Linbo

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference25 articles.

1. Clinical notice for American Society of Clinical Oncology College of American Pathologists guideline recommendations on ER/PgR and HER2 testing in breast cancer;Hammond;J. Clin. Oncol.,2011

2. Re: predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria;Wolff;J. Natl. Cancer Inst.,2012

3. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease;Press;Cancer Res.,1993

4. HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas;Press;J. Clin. Oncol.,1997

5. When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer;Yamauchi;J. Clin. Oncol.,2001

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-Low Luminal Breast Carcinoma Is Not a Homogenous Clinicopathological and Molecular Entity;Cancers;2024-05-25

2. Quantitative assessment of the breast cancer marker HER2 using a gold nanoparticle-based lateral flow immunoassay;Nano Research;2024-02-01

3. A sandwich-type electrochemical immunosensor for sensitive detection of HER2 based on dual signal amplification of La-MOF-PbO2 and PEI-MoS2NFs composites;Bioelectrochemistry;2023-08

4. Low HER2 expression is a predictor of poor prognosis in stage I triple-negative breast cancer;Frontiers in Oncology;2023-03-27

5. Biomimetic nanochannels for molybdate transport: application to sensitive electrochemical immunoassay for HER2;Microchimica Acta;2023-01-14